- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Lutetium (177Lu) edotreotide
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
Lutetium (177Lu) edotreotide
| EU orphan designation number: | EU/3/14/1269
|
| Active ingredient: | Lutetium (177Lu) edotreotide |
| Indication: | Treatment of gastro-entero-pancreatic neuroendocrine tumours |
| Sponsor: | ITG Isotope Technologies Garching GmbH
Lichtenbergstr. 1, D-85748 Garching, Deutschland |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 06/06/2014 | Orphan designation | EMA/OD/196/13 | (2014)3855 of 04/06/2014 |
CONTACT
EU links
Directorate General Health & Consumers